Transcat Reports 4% Increase in Operating Income for Fiscal 2013 First Quarter

<0> Transcat, Inc.John J. Zimmer, 585-352-7777Chief Financial OfficerorDeborah K. Pawlowski, 716-843-3908Investor Relations </0>

Transcat, Inc. (NASDAQ: TRNS) (“Transcat” or the “Company”), a leading distributor of professional grade handheld test, measurement and control instruments and accredited provider of calibration, repair, inspection and other compliance services, today reported financial results for its first quarter ended June 30, 2012. Included in reported results are those of Newark Corporation’s calibration services business, which the Company acquired on September 8, 2011.

Fiscal 2013 first quarter net revenue decreased 2.0%, or $0.5 million, to $25.1 million compared with the first quarter of the prior fiscal year as a 3.7% increase in Service segment net revenue partially offset lower Product segment net sales.

Net income was $0.4 million, or $0.05 per diluted share, in the first quarter of fiscal 2013, an increase of 11.1% over net income from the same quarter of the prior fiscal year.

Charles P. Hadeed, President and CEO of Transcat, commented, “The struggling US economy had an impact on our first quarter. Sales in our Product segment were impacted by a clear reduction in orders in April and May with the decline particularly evident in our industrial customer base. Service segment growth from acquisitions helped to offset this impact.”

Operating income for the first quarter of fiscal 2013 was $0.6 million, an increase of 4.2% from the prior fiscal year period. Operating margin improved 20 basis points to 2.4% in the first quarter of fiscal 2013 compared with 2.2% for the same quarter of the prior fiscal year. Total operating expenses declined $0.1 million, or 2.0%, to $5.6 million in the first quarter of fiscal 2013, when compared with the prior fiscal year period. During the first quarter of fiscal 2013, lower year-over-year stock-based compensation expense was partially offset by one-time Service segment sales organization restructuring charges. As a percentage of net revenue, operating expenses were relatively consistent in both quarters.

During the first quarter of fiscal 2013, Transcat generated $1.2 million of EBITDA (earnings before interest, taxes, depreciation and amortization), unchanged when compared with the same quarter of the prior fiscal year. See Note 1 on page 3 for a description of this non-GAAP financial measure and page 8 for the table.

Product segment net sales declined 4.8%, or $0.8 million, to $16.4 million in the first quarter of fiscal 2013, primarily due to sluggish economic conditions and compared with unusually strong product sales in the first quarter of fiscal 2012. Both direct sales to end users and sales to resellers were down in the first quarter of fiscal 2013.

Average Product segment net sales per day were $260 thousand in the first quarter of fiscal 2013, down 3.0% from $268 thousand in the first quarter of fiscal 2012. Online sales of the Company’s products increased 26.4% to $1.9 million, or 11.9% of Product segment net sales, in the first quarter of fiscal 2013 compared with $1.5 million, or 8.9% of Product segment net sales, in the prior year period. In spite of the overall sluggish US product market, online product sales have continued to increase at a double-digit rate, as a result of increased online marketing initiatives.

Product segment gross profit in the first quarter of fiscal 2013 declined 1.4% to $4.2 million from $4.3 million in the first quarter of fiscal 2012. As a percent of net sales, gross profit improved to 25.7% in the fiscal 2013 first quarter compared with 24.8% in the prior year period. The gross margin expansion was the result of increased cooperative advertising income.

Product segment operating income increased 3.8% to $0.9 million in the first quarter of fiscal 2013, while operating margin was 5.2% and 4.8% of Product segment net sales in the first quarters of fiscal 2013 and 2012, respectively.

Product segment EBITDA was $1.1 million, or 6.6% of Product segment sales in the first quarter of fiscal 2013, compared with $1.1 million, or 6.2% of sales in the prior year period. See Note 1 on page 3 for a description of this non-GAAP financial measure and page 8 for the table.

S

Service segment net revenue increased 3.7%, or $0.3 million, to $8.7 million in the first quarter of fiscal 2013, from the first quarter of the prior fiscal year, this improvement was driven by incremental business from recent acquisitions, partially offset by the loss of $0.3 million in low margin revenue from services that the Company was outsourcing for a customer. The remainder of the Company’s organic Service segment revenue and volume were essentially flat when compared with the first quarter of fiscal 2012.

Service segment gross profit was $2.0 million in each of the first quarters of both fiscal 2013 and 2012. Service segment gross margin in the first quarter of fiscal 2013 declined 120 basis points from the same period in the prior fiscal year to 22.9% as a result of revenue growth coming from acquisitions rather than organic sales efforts. The incremental gross margin on acquired business revenue is typically lower than the incremental gross margin on the Company’s organically generated revenue primarily due to the lower per unit pricing historically charged by smaller, acquired companies. In the first quarter of fiscal 2013, the Company’s Service segment revenue growth was attributed to revenue from acquired businesses and, therefore, the gross margin declined.

The Service segment had an operating loss of approximately $0.3 million in each of the first quarters of both fiscal 2013 and 2012. Operating expenses associated with the Service segment in the first quarter of fiscal 2013 were consistent with the first quarter of the prior fiscal year despite approximately $0.2 million in restructuring costs related to the Service segment’s sales organization in fiscal 2013 first quarter.

The Service segment generated $0.1 million in EBITDA in the fiscal 2013 first quarter compared with $0.2 million in the first quarter of fiscal 2012. As a percentage of Service segment revenue, EBITDA for the Service segment was 1.0% and 1.9% in the first quarters of fiscal 2013 and 2012, respectively. See Note 1 below for a description of this non-GAAP financial measure and page 8 for the table.

Net cash used in operations was $2.1 million in the first quarter of fiscal 2013, compared with $0.6 million used in the first quarter of fiscal 2012. The year-over-year change was the result of working capital requirements and timing. Inventory at June 30, 2012 was $7.2 million, up from $6.4 million at the end of fiscal 2012. The Company’s inventory strategy includes larger purchases of key products from certain manufacturers in an effort to maximize on-hand availability and reduce backorders of those products with long lead times. As a result, inventory levels from quarter-to-quarter will vary based on the timing of these larger orders in relation to the quarter-end.

Capital expenditures in the first quarter of fiscal 2013 were $0.5 million compared with $0.6 million in the first quarter of fiscal 2012, and were primarily for additional service capabilities.

As of June 30, 2012, the Company had $9.1 million in remaining availability under its $15.0 million revolving credit facility.

Mr. Hadeed stated, “Coming off a strong fourth quarter to end fiscal 2012, we experienced a slower than expected start in our first quarter of fiscal 2013. The sluggish economy clearly impacted both of our business segments. We expect, at least for the near term, for this economic environment to remain unchanged. We continue to remain optimistic regarding our long term growth expectations. We expect our Product segment growth rate to be mid-single digits and our Service segment growth rate to be greater than 10%. Our Service segment remains a priority as we look to leverage our current capabilities and execute on our acquisition strategy to increase our geographic footprint, enhance our service capabilities and deepen our relationships in our targeted industries. As we acquire additional service businesses, our focus is to increase cash flow and earnings rather than gross margin. We believe the impact will be more evident in our gross profit dollars and EBITDA than in our gross margin as these businesses typically operate at a lower gross margin, but generate sufficient cash flow to provide a good return on our investment. In July 2012, we acquired Anacor Compliance Services, Inc. This acquisition was significant to Transcat as it expands our reach into the targeted life sciences industry. We expect to generate positive operating income and EBITDA from this acquisition in fiscal 2013.”

In addition to reporting net income, a U.S. generally accepted accounting principle (“GAAP”) measure, we present EBITDA (earnings before interest, income taxes, depreciation, and amortization), which is a non-GAAP measure. The Company believes EBITDA allows investors to view its performance in a manner similar to the methods used by management and provides additional insight into its operating results. EBITDA is not calculated through the application of GAAP and is not the required form of disclosure by the Securities and Exchange Commission. As such, it should not be considered as a substitute for the GAAP measure of net income and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure. The use of any non-GAAP measure may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies. See the attached table on page 8.

Transcat, Inc. is a leading provider of accredited calibration, repair, inspection and compliance services including analytical instrument qualifications, equipment and process validation. Targeted industries include life science, biotechnology, medical device, pharmaceutical and other FDA-regulated industries, industrial manufacturing, energy and utilities, chemical manufacturing and other industries. Throughout its 17 strategically located centers of excellence in the United States, Canada and Puerto Rico, Transcat delivers precise services with reliable turn-around times. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17012 scopes of accreditation are believed to be among the best in the industry.

In addition, Transcat operates as a leading distributor of professional grade handheld test, measurement and control instrumentation. Through its distribution products segment, Transcat markets and distributes premier and propriety brand instruments to nearly 15,000 customers. The Company offers access to more than 25,000 test, measurement and control products.

Transcat’s growth strategy is to expand its product and service platform comprised of a balanced suite of test products and analytical, calibration, compliance, and validation services. The goal is to deliver specialized technical services with a quality assurance approach, which maximizes document accuracy and on-time job delivery. Transcat answers the call with cGMP, GLP, and GXP compliant services. Transcat can provide life science companies with a reliable alternative service and product solution to the OEMs and to the “generalist” service providers who cannot meet the client’s specialized needs.

More information about Transcat can be found on its website at:

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as “expects,” “estimates,” “projects,” “anticipates,” “believes,” “could,” and other similar words. All statements addressing operating performance, events, or developments that Transcat, Inc. expects or anticipates will occur in the future, including but not limited to statements relating to anticipated revenue, profit margins, sales operations, its strategy to build its sales representative channel, customer preferences and changes in market conditions in the industries in which Transcat operates are forward-looking statements. Because they are forward-looking, they should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties are more fully described in Transcat’s Annual and Quarterly Reports filed with the Securities and Exchange Commission, including under the heading entitled “Risk Factors.” Should one or more of these risks or uncertainties materialize, or should any of the Company’s underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on the Company’s forward-looking statements. Except as required by law, the Company disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this press release.

FINANCIAL TABLES FOLLOW

Suggested Articles

Former Ipsen and Novartis exec Harout Semerjian has been tapped as the latest chief executive of troubled Immunomedics.

A COVID-19 vaccine developed by a Mass General spinoff is among the candidates emerging from partnerships between tech developers and bio researchers.

Vir and GlaxoSmithKline will pool their resources to develop vaccines and treatments for coronaviruses, starting with two antibodies against COVID-19.